ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
생어 시퀀스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 16.9%로 61억 4,000만 달러로 성장합니다. 예측 기간의 성장은 임상 유전체학 통합 증가, 농업 유전체학의 확대, 약물 안전성 및 약리 유전체학 증가, 산전 및 신생아 스크리닝 증가, 환경 DNA 분석 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 발전, 차세대 시퀀서 수요 증가, 임상 진단에 대한 응용 확대, 유전체학 연구에 대한 투자 증가, 맞춤형 의료에 대한 활용 확대 등이 있습니다.
향후 5년간 16.9%의 성장률 전망은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 영국과 일본에서 수입되는 고충실도 시퀀싱 시약과 모세관 전기영동 시스템에 대한 접근을 제한함으로써 미국에 심각한 문제를 야기할 수 있으며, 유전자 진단을 손상시키고 실험실의 업무 부담을 증가시킬 수 있습니다. 또한 상호 관세와 무역 긴장의 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
유전성 질환 증가는 향후 수년간 싱어 시퀀싱 시장의 성장을 촉진할 것으로 예측됩니다. 유전성 질환(유전성 장애)은 유전정보를 전달하는 유전물질인 개인의 DNA의 이상이나 돌연변이로 인해 발생하는 병입니다. 싱어 시퀀싱은 특정 유전자나 DNA 영역의 뉴클레오티드(DNA의 컴포넌트)의 정확한 순서를 결정하여 이러한 질병을 진단하는 데 사용되는 방법입니다. 예를 들어 2024년 8월 영국의 공공 의료 기관인 국립보건서비스(National Health Service)는 영국에서 약 2,300명이 지중해빈혈을 앓고 있으며, 그 중 약 800명이 정기적인 수혈에 의존하는 중증형이라고 보고했습니다. 이처럼 유전성 질환 증가가 싱거 시퀀싱 시장의 성장에 박차를 가하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 생어 시퀀스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 생어 시퀀스 시장 : 성장률 분석
세계의 생어 시퀀스 시장 실적 : 규모와 성장, 2019-2024
세계의 생어 시퀀스 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 생어 시퀀스 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 생어 시퀀스 시장 : 시퀀스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
샷건 시퀀싱
표적 유전자 시퀀싱
기타 시퀀스
세계의 생어 시퀀스 시장 : 연구실별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
습식 실험실
건식 실험실
세계의 생어 시퀀스 시장 : 조사별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
사내
아웃소싱
세계의 생어 시퀀스 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단
바이오마커 갈지 않아
생식 보건
맞춤형 의료
법의학
기타 용도
세계의 생어 시퀀스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
아카데믹
정부 조사기관
제약회사
바이오테크놀러지 기업
병원
클리닉
세계의 생어 시퀀스 시장 : 서브 세분화 샷건 시퀀싱(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
전게놈 샷건 시퀀싱
메타게놈 샷건 시퀀싱
세계의 생어 시퀀스 시장 : 서브 세분화 표적 유전자 시퀀싱(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
엠플리콘 시퀀싱
엑솜 시퀀싱
세계의 생어 시퀀스 시장 : 서브 세분화 기타 시퀀스(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
네스트 PCR 시퀀싱
SBS(Sequencing By Synthesis)
제7장 지역별·국가별 분석
세계의 생어 시퀀스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 생어 시퀀스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
생어 시퀀스 시장 : 경쟁 구도
생어 시퀀스 시장 : 기업 개요
Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Beckman Coulter
PerkinElmer Inc.
BGI Group
LGC Limited
GenScript
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
Macrogen Inc.
GENEWIZ Inc.
Quintara Biosciences
CeMIA SA
Source BioScience
Microsynth AG
Fasteris SA
GenHunter Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
생어 시퀀스 시장 2029 : 새로운 기회를 제공하는 국가
생어 시퀀스 시장 2029 : 새로운 기회를 제공하는 부문
생어 시퀀스 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.
Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.29 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.
The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.14 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.
The forecast of 16.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to high-fidelity sequencing reagents and capillary electrophoresis systems imported from the UK and Japan, potentially compromising genetic diagnostics and increasing lab operational burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.
Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.
In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.
Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies
North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sanger Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sanger sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
2) By Laboratory: Wet Labs; Dry Labs
3) By Research: In-House; Outsourced
4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sanger Sequencing Market Characteristics
3. Sanger Sequencing Market Trends And Strategies
4. Sanger Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Sanger Sequencing Growth Analysis And Strategic Analysis Framework
5.1. Global Sanger Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sanger Sequencing Market Growth Rate Analysis
5.4. Global Sanger Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sanger Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sanger Sequencing Total Addressable Market (TAM)
6. Sanger Sequencing Market Segmentation
6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Shotgun Sequencing
Targeted Gene Sequencing
Other Sequencing
6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wet Labs
Dry Labs
6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In-House
Outsourced
6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Biomarkers and Cancer
Reproductive Health
Personalized Medicine
Forensics
Other Applications
6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic
Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals
Clinics
6.6. Global Sanger Sequencing Market, Sub-Segmentation Of Shotgun Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Shotgun Sequencing
Metagenomic Shotgun Sequencing
6.7. Global Sanger Sequencing Market, Sub-Segmentation Of Targeted Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amplicon Sequencing
Exome Sequencing
6.8. Global Sanger Sequencing Market, Sub-Segmentation Of Other Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nested PCR Sequencing
Sequencing By Synthesis (SBS)
7. Sanger Sequencing Market Regional And Country Analysis
7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
